What anti‑emetic medications are appropriate for a patient with benign paroxysmal positional vertigo (BPPV)?

Anti-Nausea Medications for BPPV

Antinausea medications should only be used for immediate symptomatic relief of nausea and vomiting in BPPV, not as primary treatment—the definitive treatment is canalith repositioning procedures (Epley maneuver), not medications. 1

Primary Treatment Approach

The 2017 AAO-HNS Clinical Practice Guideline explicitly states that medications are not used for BPPV treatment other than for relief of immediate distress, such as nausea 1. The guideline makes a strong recommendation against routinely treating BPPV with vestibular suppressant medications such as antihistamines and/or benzodiazepines 1.

Evidence Against Routine Medication Use

A 2023 systematic review and meta-analysis found that:

• Vestibular suppressants may have no effect on symptom resolution at 14-31 days follow-up 2
• Canalith repositioning maneuvers are superior to vestibular suppressants (RR 0.63,95% CI 0.52-0.78) 2
• Medications showed uncertain effects on 24-hour symptom resolution, repeat ED visits, patient satisfaction, and quality of life 2

When to Use Antinausea Medications

Use antiemetics only in these specific situations:

• Acute nausea/vomiting during the diagnostic Dix-Hallpike test or repositioning maneuvers 1
• Immediate post-procedure distress when patients experience brief vertigo, nausea, and disorientation during treatment 1
• Short-term symptom management (hours to days) while awaiting definitive repositioning treatment

Appropriate Medication Options

While the guidelines don't specify particular agents, traditional vestibular suppressants used for acute symptom relief include:

• Antihistamines (e.g., meclizine, dimenhydrinate)
• Anticholinergics (e.g., scopolamine)
• Benzodiazepines (e.g., diazepam, lorazepam)
• Phenothiazines (e.g., prochlorperazine, promethazine)

3, 4

Critical Pitfalls to Avoid

Do not prescribe vestibular suppressants as primary or ongoing treatment because:

1. They may slow central vestibular compensation, potentially prolonging recovery 3
2. They have sedating effects that increase fall risk—particularly dangerous since BPPV patients already have increased fall risk 1
3. They provide no benefit for the underlying mechanical problem (displaced otoconia) 2
4. They represent suboptimal care when effective mechanical treatment (80% success rate with 1-3 repositioning treatments) is available 1

Optimal Management Algorithm

1. Diagnose with Dix-Hallpike test (posterior canal) or supine roll test (horizontal canal)
2. Immediately perform canalith repositioning procedure (Epley maneuver for posterior canal BPPV)
3. Offer antiemetic only if needed for acute nausea during/immediately after the procedure
4. Discontinue medications within 24-48 hours to avoid interfering with vestibular compensation
5. No postural restrictions needed after repositioning 1

The 2023 evidence reinforces that canalith repositioning maneuvers, not medications, should be the primary treatment for BPPV 2, 5. Antiemetics serve only as temporary adjuncts for symptom control, not therapeutic agents.